Leadership

R. Steven Paulson, M.D., is president and chief executive officer of Precision Health Informatics, a data science and technology company founded in 2021 and dedicated to using data-driven insights and evidence-based learning to transform cancer patient outcomes and experiences.

An early pioneer in applying precision medicine to oncology, Dr. Paulson has been a strong advocate for using big data to improve outcomes for cancer patients by giving physicians real-time access to this information. Through advanced data technology and insights, Precision Health Informatics mines extensive patient records and real-world experience to give physicians real-time access to potential therapies and insights to make the best treatment decisions at the bedside.

Dr. Paulson specializes in medical oncology and hematology and is board certified in medical oncology by the American Board of Internal Medicine.

Dr. Paulson received his Bachelor of Science in chemistry from Texas A&M University in 1972 and his medical degree from The University of Texas Southwestern Medical School in Dallas, Texas, in 1977. He received training in internal medicine at Peter Bent Brigham Hospital in Boston, Mass., from 1977 to 1979, and completed training in internal medicine at Parkland Memorial Hospital in Dallas, Texas, from 1979 to 1980, where he also completed a fellowship in hematology and oncology from 1980 to 1982. Dr. Paulson received additional training at the bone marrow transplant unit at Fred Hutchinson Cancer Center in Seattle, Wash., in 1982.

Dr. Paulson is a member of the American College of Physicians, American Society of Clinical Oncology, and Texas Medical Association. He served on the Texas Society of Medical Oncology board of directors and as its president in 1991.

Lori Brisbin, M.S., M.L.S Healthcare Law, introduced and now leads the precision medicine program at Texas Oncology, which is focused on patient care, research, and maximizing the opportunities for clinical trial participation for our patients. Her team is responsible for developing and implementing clinical diagnostic pathways for increasing the appropriate use of complete genomic profiling across the practice. The precision medicine program is also responsible for developing and maintaining various data sources, including the electronic medical record, pharmacy management system, and molecular data warehouse, which houses more than 200,000 molecular profiles.

Brisbin has a Bachelor of Science degree in biology from the University of Albany, New York, and a Master of Science degree in molecular biology from Syracuse University, where she studied cell signaling pathways and genetic engineering. She also has a Master of Legal Studies in healthcare law from the University of Oklahoma.

Prior to joining Texas Oncology, Lori worked in HIV research for the molecular virology program at the National Institutes of Health under the oversight of Robert C. Gallo, M.D. Brisbin then transitioned to industry, working with several diagnostic and pharmaceutical companies in domestic and global markets, including Roche Molecular Systems and Novartis. Brisbin specializes in product development and commercialization of new technologies and markets, such as molecular virology, nucleic acid blood screening and precision oncology.

Laura M. Gajewsk is the Director of Business Development, Precision Medicine at Precision Health Informatics. She leads efforts to drive growth, cultivate strategic relationships with life science and pharmaceutical companies, payors, and data aggregators by providing access to a broad array of datasets that contribute to meaningful research efforts in healthcare, including drug development and achieving successful clinical outcomes. With two decades in laboratory diagnostics and cancer therapeutics, Gajewski is a recognized leader in precision medicine, oncology, and bioinformatics. For the past 12+ years, she has focused on advancing diagnostic testing options and therapeutic treatments for cancer.

Gajewski has a bachelor’s degree in occupational therapy from Texas State University in San Marcos, Texas. She has previously held various sales and management roles at LabCorp, HealthTronics, Endo Pharmaceuticals, and MedFusion/The US Oncology Network. Her expertise spans a wide range of diagnostic methodologies and the implementation of innovative technologies that increase the accuracy and efficacy of cancer treatments. She has led strategic initiatives to improve cancer care using innovative lab solutions and bioinformatics. Her work involves utilizing AI-driven real-world data (RWD) and molecular profiling to enhance diagnostic accuracy and connect patients with effective treatment options through personalized medicine.

Gajewski’s deep understanding of cancer diagnostics and treatment options allows her to contribute significantly to initiatives focused on transforming cancer care. Her career has been dedicated to making a real impact in the fight against cancer by delivering value-driven solutions that enhance the patient journey.

As the chief medical officer of Precision Health Informatics, Sreeni Chittoor, M.D., works closely with the team to seek educational opportunities in the area of precision oncology, collaborating with members of the life sciences industry to improve patient care and clinical outcomes.

He has held an interest in direct interaction with life science partners and laboratory pathologists to discuss patient care, in turn, giving pathologists a clear clinical picture of the patient. This understanding and relationship between the laboratory and the clinician is vital for the delivery of appropriate care for each individual patient.

Dr. Chittoor played an instrumental role in Precision Health Informatics first Virtual Molecular Tumor Board (VMTB) using the NAVIFY® platform. The customization of this software solution enabled the integration of different clinical datasets to identify the most effective therapy for patients based on each patient’s entire molecular profile, thus providing future clinical trial opportunities.

A practicing hematologist and medical oncologist, Dr. Chittoor received his medical doctorate in 1979 from Guntur Medical College in India. He completed his internship and residency in internal medicine at Georgetown University Medical Service, D.C. General Hospital, Washington, D.C., in 1988.

Dr. Chittoor completed his medical oncology fellowship in 1990 at the Vincent Lombardi Cancer Research Center, Georgetown University Medical Center in Washington, D.C. This fellowship included training in bone marrow transplantation and advanced training at the Biological Response Modifiers Program at the National Cancer Institute in Maryland. Dr. Chittoor completed an additional fellowship in hematology at Georgetown University Medical Center in 1991.

In addition to providing patient care, Dr. Chittoor is the area director for two cancer centers in the Dallas Metroplex. This role involves the development and direction of physician clinical services to build a patient-centered oncology program.

Dr. Chittoor is the co-author of several publications and abstracts and is licensed to practice medicine in the states of Texas, Florida, and California.

Dr. Gandhi is a practicing hematologist and medical oncologist, C-suite executive, entrepreneur, and ex-strategic venture capitalist with a passion to drive personalized oncology care powered by innovation in biology and data science.

In his role as chief scientific officer with Precision Health Informatics, Dr. Gandhi works with the executive leadership to invest in new technology and AI solutions in data science. He leads implementation and assists the data science team with data curation and mining, working with other oncologists to identify and implement clinical use cases. Additionally, he is active in the business development side of Precision Health Informatics, forging relationships with pharma and data aggregator partners and collaborators.

Board certified in hematology and medical oncology, Dr. Gandhi is an accomplished operator with several oncology companies in the space of real-world data and drug discovery. He directed strategy and innovation at a large VC-backed analytics company where he was instrumental in scaling operations, sales, raising capital, and positioning for mergers and acquisitions. In a prior role, he served as the executive director of Innovation/Venture for one of the largest Texas-based healthcare systems where he led strategic investments in early-mid stage companies.

Dr. Gandhi completed the Advanced Management Program at the Harvard Business School and was elected class secretary. He earned an MBA from the Isenberg School of Management, University of Massachusetts, and completed medical training at the University of Iowa Hospitals and Clinics. Dr. Gandhi is a mentor and advisor at the Harvard Innovation Labs in Boston and remains actively involved with the Broad Institute of MIT and Harvard in Cambridge, MA.

A member of the American College of Physicians, American Medical Association, American Society of Clinical Oncology, American Society of Hematology, and American College of Healthcare Executives, Dr. Gandhi is a national speaker and author with a primary focus on healthcare innovation, especially in oncology.

​​Charles S. White, III, M.D., previously served as vice president, area director, and executive vice president, managing director for Texas Oncology. In his role as strategic consulting advisor with Precision Health Informatics, Dr. White brings decades of medical oncology experience, participating in activities and discussions with Precision Health Informatics principals. He realizes the value that resides in Precision Health Informatics by giving and the fact that physicians will have access to the next generation search engine.

Dr. White has served as a member of The US Oncology Network’s National Policy Board and Executive Committee of Pharmacy and Therapeutics. He also served as president of the medical staff at Medical City Dallas in Dallas, Texas. Dr. White is a member of the American Society of Clinical Oncology, Dallas County Medical Society, Texas Medical Association, American Society of Hematology, and Texas Society of Medical Oncology.

He earned his medical degree from University of Pittsburgh School of Medicine in Pittsburgh, Pennsylvania, in 1969, and completed his internship and residency in internal medicine at Dallas Veterans Administration Hospital, Dallas, Texas, in 1970 and 1971, respectively. Dr. White served a fellowship in hematology and medical oncology at The George Washington University Medical Center, in Washington, D.C., from 1974-1976. He earned a Bachelor of Arts from Harvard University in 1965.